| scholarly article | Q13442814 |
| P2093 | author name string | J P Noel | |
| M E Bowman | |||
| D E Cane | |||
| C Chow | |||
| I Kang | |||
| W Kwiatkowski | |||
| S B Richard | |||
| A M Lillo | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 641-8 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Nature structural biology | Q26842658 |
| P1476 | title | Structure of 4-diphosphocytidyl-2-C- methylerythritol synthetase involved in mevalonate- independent isoprenoid biosynthesis | |
| P478 | volume | 8 |
| Q42722311 | A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling |
| Q37399629 | A structural and functional study on the 2-C-methyl-d-erythritol-4-phosphate cytidyltransferase (IspD) from Bacillus subtilis |
| Q37899789 | Biochemistry of the non-mevalonate isoprenoid pathway |
| Q27641732 | Biosynthesis of isoprenoids: Crystal structure of 4-diphosphocytidyl-2C-methyl-D-erythritol kinase |
| Q24681801 | Characterization of the Mycobacterium tuberculosis 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase: potential for drug development |
| Q39404964 | Chemoenzymatic synthesis of 4-diphosphocytidyl-2-C-methyl-D-erythritol: A substrate for IspE. |
| Q37872624 | Convergent strategies in biosynthesis |
| Q27636755 | Crystal structure of 1-deoxy-D-xylulose-5-phosphate reductoisomerase, a crucial enzyme in the non-mevalonate pathway of isoprenoid biosynthesis |
| Q50043356 | Crystal structure of IspF from Bacillus subtilis and absence of protein complex assembly among IspD/IspE/IspF enzymes in the MEP pathway |
| Q27676521 | Experimental and computational active site mapping as a starting point to fragment-based lead discovery |
| Q33610129 | Expression and characterization of soluble 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase from bacterial pathogens. |
| Q30377207 | Fractal Dimensions of Macromolecular Structures. |
| Q28743804 | Francisella tularensis 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase: kinetic characterization and phosphoregulation |
| Q44363679 | Functional expression and characterization of EryA, the erythritol kinase of Brucella abortus, and enzymatic synthesis of L-erythritol-4-phosphate |
| Q45091600 | Hexameric assembly of the bifunctional methylerythritol 2,4-cyclodiphosphate synthase and protein-protein associations in the deoxy-xylulose-dependent pathway of isoprenoid precursor biosynthesis |
| Q43241599 | Homology modeling of Mycobacterium tuberculosis 2C-methyl-D-erythritol-4-phosphate cytidylyltransferase, the third enzyme in the MEP pathway for isoprenoid biosynthesis. |
| Q24316024 | ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome |
| Q59112547 | Identification and Characterization of Bioactive Compounds Targeting UropathogenicEscherichia colifrom Sanjin Tablets |
| Q44512423 | Identification of lethal mutations in Escherichia coli genes encoding enzymes of the methylerythritol phosphate pathway |
| Q36451494 | Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly |
| Q28727252 | Isoprenoid precursor biosynthesis offers potential targets for drug discovery against diseases caused by apicomplexan parasites |
| Q34353900 | Lethal mutations in the isoprenoid pathway of Salmonella enterica |
| Q37503777 | Mechanistic aspects of carotenoid biosynthesis. |
| Q38219650 | Methylerythritol 4-phosphate (MEP) pathway metabolic regulation |
| Q37421946 | Molecular Mechanism of Action of Antimalarial Benzoisothiazolones: Species-Selective Inhibitors of the Plasmodium spp. MEP Pathway enzyme, IspD |
| Q28078674 | New Insight into Isoprenoids Biosynthesis Process and Future Prospects for Drug Designing in Plasmodium |
| Q36467783 | Plasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target |
| Q38258972 | Probing phosphorylation by non-mammalian isoprenoid biosynthetic enzymes using (1)H-(31)P-(31)P correlation NMR spectroscopy. |
| Q35165298 | Production of rubber-like polymers by microorganisms |
| Q27688950 | Pseudilins: halogenated, allosteric inhibitors of the non-mevalonate pathway enzyme IspD |
| Q45211611 | Resurrecting the ancestral enzymatic role of a modulatory subunit |
| Q27667712 | Structural and functional studies of mycobacterial IspD enzymes |
| Q34749965 | Structural genomics of proteins from conserved biochemical pathways and processes |
| Q27637260 | Structure and mechanism of 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase. An enzyme in the mevalonate-independent isoprenoid biosynthetic pathway |
| Q27636191 | Structure and mechanism of CTP:phosphocholine cytidylyltransferase (LicC) from Streptococcus pneumoniae |
| Q27638950 | Structure of 2C-methyl-D-erythritol 2,4- cyclodiphosphate synthase: an essential enzyme for isoprenoid biosynthesis and target for antimicrobial drug development |
| Q60301840 | Synthesis and Kinetic evaluation of an azido analogue of methylerythritol phosphate: a Novel Inhibitor of E. coli YgbP/IspD |
| Q27649129 | Synthesis and characterization of cytidine derivatives that inhibit the kinase IspE of the non-mevalonate pathway for isoprenoid biosynthesis |
| Q27653131 | Synthesis of CDP-Activated Ribitol for Teichoic Acid Precursors in Streptococcus pneumoniae |
| Q36561313 | Targeting the formation of the cell wall core of M. tuberculosis |
| Q35710557 | Terpene Specialized Metabolism in Arabidopsis thaliana |
| Q56994497 | The MEP pathway and the development of inhibitors as potential anti-infective agents |
| Q37107614 | The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target |
| Q27642625 | The crystal structure of murine CMP-5-N-acetylneuraminic acid synthetase |
| Q32884479 | The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition |
| Q36795133 | The non-mevalonate pathway of isoprenoid precursor biosynthesis. |
| Q36066272 | The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs |
Search more.